There remains a critical need to improve success rates for oncologic surgery.  Currently, surgeons can only make gross estimations of what should be removed during the cancer resection.

As an oncologic surgeon with a lab that has explored the role of optical imaging to improve cancer surgery over the past decade, Dr. Rosenthal is uniquely suited to assist with the translation of this technology to the clinic; his lab is uniquely suited to conduct preclinical research and clinical translation of novel imaging modalities in cancer treatement.